Supernus Pharmaceuticals to Acquire Sage Therapeutics, Strengthening its Neuropsychiatry Product Portfolio - Sage Therapeutics
Last Updated: 18.06.2025 13:36
</li><li>Strengthens Supernus leading presence in neuropsychiat… [+21469 chars]
<ul><li>Proposed acquisition expected to accelerate mid- to long-term revenue and cash flow growth and further diversify revenue base.